Rhabdoid tumor predisposition syndrome with renal tumor 10 years after brain tumor.
|
| Abstract |
We report a case of rhabdoid tumor predisposition syndrome with a renal tumor developing 10 years after a brain tumor, which demonstrated an unexpectedly favorable outcome. A 2-year-old boy underwent gross total resection of a brain tumor located in the fourth ventricle, and received adjuvant chemotherapy and radiotherapy. At the age of 11 years, a renal tumor was found and nephrectomy was performed. He is currently alive without evidence of disease over 2 years without postoperative therapy. Histologically, rhabdoid cells were observed in both brain and renal tumors. Loss of SMARCB1 (also known as INI1) expression was found in the nucleus of both tumor cells. Genetic testing revealed pathogenic variants of SMARCB1 exon 5 in the renal tumor and SMARCB1 exon 9 in the brain tumor. In addition, heterozygous deletion of 22q11.21-q11.23 containing the SMARCB1 locus was shared by both tumors and this deletion was identified in normal peripheral blood. Considering the histopathological and genetic findings, our case was considered to be rhabdoid tumor predisposition syndrome with atypical teratoid/rhabdoid tumor and late-onset rhabdoid tumor of the kidney.
|
|---|---|
| Authors | Hiroko Fukushima, Kai Yamasaki, Miho Sakaida, Nozomi Tsujio, Takahiro Okuno, Naomi Ishii, Keiko Okada, Hiroyuki Fujisaki, Yasuhiro Matsusaka, Hiroaki Sakamoto, Akihiro Yoneda, Junichi Hara, Takeshi Inoue |
| Journal | Pathology international (Pathol Int) Vol. 71 Issue 2 Pg. 155-160 (Feb 2021) ISSN: 1440-1827 [Electronic] Australia |
| PMID | 33378586 (Publication Type: Case Reports) |
| Copyright | © 2020 Japanese Society of Pathology and John Wiley & Sons Australia, Ltd. |
| Chemical References |
|
| Topics |
|
Join CureHunter, for free Research Interface BASIC access!
Realize the full power of the drug-disease research graph!